| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047904700 |
| P356 | DOI | 10.1007/S12031-016-0812-X |
| P932 | PMC publication ID | 5026716 |
| P698 | PubMed publication ID | 27525637 |
| P50 | author | David Collier | Q21094975 |
| Olympia Gianfrancesco | Q51418502 | ||
| John P Quinn | Q41818693 | ||
| P2093 | author name string | Paul Myers | |
| Vivien J Bubb | |||
| Daniel Griffiths | |||
| P2860 | cites work | MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1 | Q24630616 |
| The schizophrenia risk gene product miR-137 alters presynaptic plasticity. | Q27312392 | ||
| The structure of haplotype blocks in the human genome | Q27860500 | ||
| Genome-wide association study identifies five new schizophrenia loci | Q28248384 | ||
| Genome-wide association analysis identifies 13 new risk loci for schizophrenia | Q28297287 | ||
| HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants | Q29614906 | ||
| Integrative analysis of 111 reference human epigenomes | Q29615565 | ||
| Cross talk between microRNA and epigenetic regulation in adult neurogenesis | Q33788417 | ||
| Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. | Q33924728 | ||
| A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder | Q34657883 | ||
| Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholism | Q35222822 | ||
| A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity | Q37015341 | ||
| Analysis of the effects of depression associated polymorphisms on the activity of the BICC1 promoter in amygdala neurones | Q37150743 | ||
| Polymorphic variation as a driver of differential neuropeptide gene expression | Q38161098 | ||
| Characterisation of multiple regulatory domains spanning the major transcriptional start site of the FUS gene, a candidate gene for motor neurone disease. | Q38934628 | ||
| Transcriptional targets of the schizophrenia risk gene MIR137. | Q38979078 | ||
| A remote and highly conserved enhancer supports amygdala specific expression of the gene encoding the anxiogenic neuropeptide substance-P. | Q40359293 | ||
| Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets | Q45263643 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 239-247 | |
| P577 | publication date | 2016-08-15 | |
| P1433 | published in | Journal of Molecular Neuroscience | Q15708870 |
| P1476 | title | Identification and Potential Regulatory Properties of Evolutionary Conserved Regions (ECRs) at the Schizophrenia-Associated MIR137 Locus | |
| P478 | volume | 60 |
Search more.